Skip to Content
Merck
CN

206571

6-Methoxy-8-nitroquinoline

99%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C10H8N2O3
CAS Number:
Molecular Weight:
204.18
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
201-633-7
MDL number:
Assay:
99%
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

99%

form

powder

mp

158-160 °C (lit.)

functional group

nitro

SMILES string

COc1cc([N+]([O-])=O)c2ncccc2c1

InChI

1S/C10H8N2O3/c1-15-8-5-7-3-2-4-11-10(7)9(6-8)12(13)14/h2-6H,1H3

InChI key

MIMUSZHMZBJBPO-UHFFFAOYSA-N

Application

6-Methoxy-8-nitroquinoline was used in the synthesis of:
  • 6-methoxy-8-aminoquinoline, metabolite of primaquine
  • 6-methoxy-8-hydroxylaminoquinoline
  • 2-substituted/2,5-disubstituted-6-methoxy-8-nitroquinolines


pictograms

Health hazardExclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



L J Bolchoz et al.
The Journal of pharmacology and experimental therapeutics, 297(2), 509-515 (2001-04-17)
Primaquine is an important antimalarial agent because of its activity against exoerythrocytic forms of Plasmodium spp. However, methemoglobinemia and hemolytic anemia are dose-limiting side effects of primaquine therapy that limit its efficacy. These hemotoxicities are thought to be mediated by
Suryanarayana Vangapandu et al.
Bioorganic & medicinal chemistry, 12(10), 2501-2508 (2004-04-28)
We report in vitro antimycobacterial properties of ring-substituted quinolines (series 1-4) constituting 56 analogues against drug-sensitive and drug-resistant M. tuberculosis H37Rv strains. The most effective compounds 2h (R1 = R2 = c-C6H11, R3 = NO2, series 1) and 13g (R1



Global Trade Item Number

SKUGTIN
206571-1G04061826257234